While attending the International Symposium on Endovascular Therapy, Cardiology Today’s Intervention had the opportunity meet with some of the leading minds in the field.
In this video exclusive, we asked William A. Gray, MD, from Main Line Health and Lankenau Heart Institute in Wynnewood, Pennsylvania; Cardiology Today’s Intervention Editorial Board Member Michael R. Jaff, DO, FSCAI, from Newton-Wellesley Hospital in Newton, Massachusetts and Harvard Medical School; ISET 2018 lead program director Barry T. Katzen, MD, from Miami Cardiac and Vascular Institute at Baptist Health South Florida; and Jihad A. Mustapha, MD, FACC, FSCAI, from Advanced Cardiac and Vascular Amputation Centers in Grand Rapids, Michigan their current thoughts on the most interesting areas in vascular intervention.
Watch for more.
Disclosures: Gray reports he consults for Abbott Vascular, Boston Scientific, Cardiovascular Systems Inc., Cook Medical, Cordis, Medtronic, Shockwave Medical and W.L. Gore and Associates and holds stock in Biocardia, Coherex Medical, Contego Medical and Silk Road Medical. Jaff reports he consults for Abbott Vascular, American Orthotics and Prosthetics Association, Boston Scientific, Cordis/Cardinal Health, Medtronic, Micell and Philips/Volcano and holds stock in Embolitech, Janacare, PQ Bypass, Sano V, Vacutronix, Vascular Therapies and Venarum. Katzen reports he consults for Boston Scientific, Graftworx, Philips and W.L. Gore and Associates and receives other financial or material support from Boston Scientific, Philips and W.L. Gore and Associates. Mustapha reports he consults for Abbott Vascular, Bard Peripheral Vascular, Boston Scientific, Cardiovascular Systems Inc., Cook Medical, Medtronic, Spectranetics and Terumo.